PFIZER
|
PFIZER Last 5 Year Cashflow Statement History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit Before Tax | ₹1,016 Cr | ₹746 Cr | ₹824 Cr | ₹773 Cr | ₹669 Cr |
Adjustment | ₹-257 Cr | ₹-89 Cr | ₹-131 Cr | ₹76 Cr | ₹55 Cr |
Changes In working Capital | ₹57 Cr | ₹-246 Cr | ₹-34 Cr | ₹44 Cr | ₹-92 Cr |
Cash Flow after changes in Working Capital | ₹816 Cr | ₹411 Cr | ₹658 Cr | ₹893 Cr | ₹631 Cr |
Cash Flow from Operating Activities | ₹660 Cr | ₹257 Cr | ₹356 Cr | ₹667 Cr | ₹427 Cr |
Cash Flow from Investing Activities | ₹-71 Cr | ₹54 Cr | ₹-36 Cr | ₹-575 Cr | ₹-469 Cr |
Cash Flow from Financing Activities | ₹-205 Cr | ₹-235 Cr | ₹-346 Cr | ₹-181 Cr | ₹-1,571 Cr |
Net Cash Inflow / Outflow | ₹383 Cr | ₹75 Cr | ₹-26 Cr | ₹-88 Cr | ₹-1,613 Cr |
Opening Cash & Cash Equivalents | ₹112 Cr | ₹37 Cr | ₹63 Cr | ₹151 Cr | ₹1,764 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹495 Cr | ₹112 Cr | ₹37 Cr | ₹63 Cr | ₹151 Cr |
Compare Cashflow Statement of peers of PFIZER
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PFIZER | ₹24,298.7 Cr | -3% | 3% | -7.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,218.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,158.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹126,710.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,586.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,496.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
PFIZER Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PFIZER | -3% |
3% |
-7.7% |
SENSEX | 1.6% |
2.1% |
2.6% |
You may also like the below Video Courses